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Esophageal Pulse Oximetry Utilizing Reflectance
Photoplethysmography
Panayiotis A. Kyriacou*, Member IEEE, Sarah Powell, Richard M. Langford, and Deric P. Jones, Member IEEE
Abstract—Peripheral perfusion is often poor and barely
pulsatile in patients undergoing prolonged major surgery. Hence,
the arterial blood oxygen saturation (SpO2) readings from
commercial finger pulse oximeters can become unreliable or
cease when they are most needed. To overcome this limitation, the
esophagus has been investigated as an alternative measurement
site, as perfusion may be preferentially preserved centrally. A
reflectance esophageal pulse oximeter probe, and a processing
system implemented in LabVIEW were developed. The system was
evaluated in clinical measurements on 49 cardiothoracic surgery
patients. The SpO2 values from the esophagus were in good
agreement with arterial blood oxygen saturation (SaO2) values
obtained from blood gas analysis and CO-oximetry. The means
( SD) of the differences between the esophageal SpO2 and SaO2
results from blood gas analysis and CO-oximetry were 0.02
0.88% and 0.73 0.72%, respectively. In five (10.2%) of the pa-
tients, the finger pulse oximeter failed for at least 10 min while the
esophageal SpO2 readings remained reliable. The results confirm
that the esophagus may be used as an alternative monitoring site
for pulse oximetry even in patients with compromised peripheral
perfusion.
Index Terms—Esophagus, pulse oximetry.
I. INTRODUCTION
PULSE oximeters are noninvasive, easy to use, and readilyavailable. Pulse oximetry provides information about the
arterial blood oxygen saturation and heart rate, and has wide-
spread clinical applications. The use of pulse oximetry has been
described in many settings: hospital, outpatient, domiciliary use
and in veterinary clinics. In the early 1990s, pulse oximetry be-
came a mandated international standard for monitoring during
anesthesia following the publication in 1986 of the Harvard min-
imum standards for monitoring. Kelleher [1] reviewed 220 ref-
erences in a review published in 1989. In a follow-up review in
1992, Severinghaus and Kelleher [2] found more than 500 new
reports between 1989 and October 1991. Nearly 2000 further
reports have been published since October 1991.
Although generally reliable, pulse oximeters do fail and
many of their limitations, both physiological (abnormal
hemoglobins, other absorbants, anemia, skin pigmentation) and
technical (signal artifact, electromagnetic interference) have
been described [3]. Pulse oximeters require adequate peripheral
perfusion to give accurate results, and they have been reported
to fail in patients with compromised peripheral perfusion
[4]–[6]. Pulse oximetry is a pulse dependent technique, and
any significant reduction in the amplitude of the pulsatile
component of the photoplethysmographic (PPG) signal de-
tected by the oximeter can lead to inaccurate values for blood
oxygen saturation (SpO ) or complete failure. When peripheral
perfusion is poor, as in states of hypovolemia, hypothermia, and
vasoconstriction, oxygenation readings become unreliable or
cease [7]–[9]. Such clinical situations occur, for example, after
prolonged operations, especially hypothermic cardiopulmonary
bypass surgery. The problem arises because conventional trans-
mission pulse oximetry sensors must be attached to peripheral
parts of the body, such as a finger, ear or toe, where pulsatile
flow is most easily compromised. Measurements at sites other
than the finger or ear, such as the forehead and nose, give no
improvement in patients with poor peripheral perfusion [10],
[11]. Thus, SpO readings may be unobtainable at just the time
when they would be most valuable.
To avoid the difficulties associated with conventional mea-
surements of arterial blood oxygen saturation during conditions
of poor peripheral perfusion and pulsation, it has been proposed
that the upper esophagus be used as a measurement site. Atlee
and Bratanow [12] presented results of blood oxygen saturation
measurements obtained at the cricopharyngeous muscle in
the upper esophagus (14 1 cm from the incisors) using
a “transoesophageal” probe where the optical components
of the oximetry sensor were incorporated into a traditional
anesthesia esophageal stethoscope. The results showed that
the “transoesophageal” probe underestimated or overestimated
SpO values depending on the geometry of the sensor [13],
[14]. In another clinical study, Prielipp et al. [15] compared this
“transoesophageal” probe with two conventional finger pulse
oximeter probes. They concluded that the “transoesophageal”
probe did not perform well as the standard finger oximetry
monitors.
The investigation of PPG signals within the whole depth
of the esophagus has been suggested [16] in an attempt to
overcome the limitations of measurements at the cricopha-
ryngeous muscle. The use of a more central monitoring site
should increase the likelihood of obtaining reliable oxygen
saturation readings even during periods of compromised
peripheral perfusion. Earlier preliminary studies on healthy
anesthetized patients categorized ASA 1 (American Standard
of Anesthesiology; scale 1–5, with five the most critically ill
patient) using a prototype system showed that measurable PPG
Fig. 1. Side and cross sectional views of the esophageal pulse oximetry probe. In the cross-sectional view, the probe is shown inserted in the esophageal tube.
signals with large amplitudes and good signal-to-noise ratio
(SNR) at two wavelengths [red (R) and infrared (IR)] could
be detected from the entire length of the esophagus [17], [16],
[18]. In the present study, a new esophageal pulse oximetry
processing system which allows the online estimation of
esophageal SpO was developed to investigate patients (ASA
2, 3, 4) undergoing high-risk operations, such as hypothermic
cardiothoracic bypass surgery. Cardiothoracic bypass patients
have an arterial cannula inserted routinely, thereby facilitating
rigorous validation of the esophageal SpO measurements
with CO-oximetry and blood gas analysis. There appears to
have been no previous report of measurements of SpO in the
esophagus below the cricopharyngeous muscle.
II. METHODS
A. Esophageal Pulse Oximeter Probe
A reflectance esophageal pulse oximeter probe was con-
structed. This new probe comprised two (IR) and two (R)
surface mount emitters and a surface mount photodetector
(Fig. 1). The photodetector detected radiation back scattered
by the tissue from both IR and R emitters and gave an output
current proportional to the detected radiation intensity. A
six-core cable carried the power to the IR and R emitters in the
probe from the main photoplethysmography (PPG) processing
unit and also the PPG signal currents from the photodetector
(Fig. 1).
1) Optical Components: The IR and R emitters used were
ceramic chip surface mount types (dimensions of each: 3.2 mm
1.27 mm) with peak emission wavelengths at 880 and 655 nm,
respectively (ELCOS GmbH). The photodetector was a surface
mount silicon PhotoPinDiode on a ceramic contact base (dimen-
sions: 4.57 mm 3.81 mm) (ELCOS GmbH).
2) Mechanical Construction of the Esophageal Pulse
Oximetry Probe: The photodetector was mounted between the
R and IR emitters to detect radiation intensity back scattered
by the tissue (Fig. 1). The emitter and photodiode chips were
mounted on the copper side of an epoxy glass copper clad
single sided eurocard (dimensions: 20 mm 3.5 mm 1.0
Fig. 2. Final position of the rubber stopper in the esophageal tube with the
esophageal pulse oximeter probe in situ.
mm). Low-temperature (200 C to 250 C) soldering was
used for connecting the surface mount components to the
copper tracks of the board. Insulated wrapping wire (30 AWG)
was used for the interconnection of the optical components.
The esophageal probe with attached cable was designed to
fit into a plastic transparent disposable stomach/esophageal
tube (Figs. 1 and 2) (Pennine Healthcare, Derby, U.K.). The
esophageal tube used was a size 20 French gauge (external
diameter: 6.66 mm; internal diameter: 4.66 mm; length: 780
mm, without X-ray detectable line) mainly used for gastric
lavage (washout) or other gastric surgical procedures. The
tube had a closed end with two side drainage holes. The
esophageal tube was sealed at the bottom to prevent gastric
juices or esophageal mucous reaching the electronic and optical
components of the probe during clinical measurements. The
sealing of the tube was achieved using a solid rubber stopper
(dimensions: upper diameter: 6 mm; lower diameter: 4 mm;
length: 14 mm) (Fisher Scientific, Loughborough, U.K.). The
rubber stopper was pushed from the upper drainage hole of the
tube toward the top of the tube (Fig. 2), until the bottom end
of the rubber stopper was situated approximately 1 cm above
the upper drainage hole of the tube. The upper diameter of the
rubber stopper is greater than the internal diameter of the tube
(diameter difference: 1.34 mm), therefore, when pushed into
the tube a tight contact with the plastic was achieved, which
kept it firmly in position. In its final position, the end of the
esophageal probe was approximately 60 mm from the distal
end of the stomach tube (Fig. 2).
Fig. 3. Detailed block diagram of the esophageal processing system.
B. Processing System Hardware
A processing system was constructed to preprocess, record
and display esophageal PPG signals on a laptop personal com-
puter (Fig. 3). To minimize the risk to the patient from the
electrical hazard associated with the accidental or unintended
mains power up of the laptop computer, the input (patient side)
and output (monitoring side) circuits of the system were iso-
lated. The input side (patient side) of the processing system
was electrically isolated from the output side (monitoring side)
using two Burr-Brown ISO122 analog isolation amplifiers and
a Burr-Brown 722BG isolated dc-to-dc converter. Esophageal
time multiplexed ac and dc PPG traces (obtained at R and IR
wavelengths) were processed by the system and digitized by a
16-bit data acquisition card. A detailed block diagram of the
processing system is shown in Fig. 3.
1) Input Side Circuitry of the Processing System: The
master clock and timing generator circuit (Fig. 3) of the
processing system comprised a crystal oscillator, a frequency
divider, and a ring shift counter. It was used to generate the
timing signals for switching (ON/OFF) the R and IR emitters.
These timing control signals were also used for synchronizing
the demultiplexer that separated the mixed (R and IR) PPG
signals at the output of the preamplifier circuit into R and IR
PPG signals. The emitters were driven by a pair of identical
constant current sources one for each wavelength. Analog
switches (MC14053) were used to time multiplex the R and
IR emitters at 75 Hz (each emitter is switched on every 13.33
ms for an interval of 3.33 ms). The constant current circuits
provided a total of 40 mA of pulse current to each pair of
emitters in parallel. The R and IR emitters were never on at
the same time, although during part of the emitter switching
cycle they were both off to allow the photodetector to detect
ambient light. The duty cycle was 25%. The R emitters were
on for the first quarter cycle, then all emitters were off for the
second quarter cycle. The IR emitters were on for the third
quarter cycle, and all were again off for the final quarter cycle.
The effect of ambient light could have been estimated during
the off periods and used to correct the results, although it was
deemed unnecessary as the esophageal pulse oximetry probe
was in “total darkness,” in the collapsed tube of the esophagus.
The preamplifier circuit (Fig. 3) consisted of a tran-
simpedance (current-to-voltage) amplifier and an inverting
amplifier. The transimpedance amplifier converted the photo-
diode current into a mixed signal voltage containing R and IR
PPGs. The negative going output signal of the transimpedance
amplifier was then inverted by a unity gain inverting amplifier.
The mixed PPG signal from the output of the inverting amplifier
was then fed into a demultiplexer (MC14052) to separate the
PPG signals into two independent channels (R and IR). The
inputs to the demultiplexer were the inverting amplifier output
and the control timing signals from the master clock and timing
generator circuit.
In order to eliminate the high-frequency (75 Hz) switching
noise from the demultiplexer, caused by the timing control sig-
nals, the R and IR PPG signals were each low-pass filtered. The
cutoff frequency was set at 40.2 Hz. The R and IR PPG signals
were then passed through the isolation barrier of the analog iso-
lation amplifier to the output side of the processing system.
2) Isolation and Output Side Circuitry of the Processing
System: Two analog isolation amplifiers were used to pass the
esophageal PPG signals (R and IR) from the input side to the
output side of the processing system (Fig. 3). The isolation
amplifiers used were Burr-Brown ISO122.
The IR and R PPG signals each consisted of a large amplitude
dcPPGcomponentandasmallamplitudeacPPGcomponent (ap-
proximately 1% to 2% of the dc component). These signals were
split into independent channels (IR ac and dc and R ac and dc)
using active filters (Fig. 3). The ac PPG components were ex-
tracted using two identical bandpass filters, one for the IR and
one for the R wavelength. The bandpass filters used consisted of a
first order high-pass filter, to block the dc PPG component, and a
Butterworthtwo-polelow-passactivefilterwhichattenuatedhigh
frequencies. The frequency response was 0.48–20 Hz (at 3 dB)
with a gain of 1.58 in the passband. The dc PPG components for
the R and IR wavelengths were extracted from the combined ac
and dc PPG signals at the output of the isolation amplifiers using
two identical unitygain two-pole, active low pass Butterworth fil-
ters with a cutoff frequency at 0.15 Hz (Fig. 3).
C. Power Supplies for Processing System
The processing system used two heavy duty ( 12 V) sealed
lead–acid rechargeable (Yuasa NP2.1-12, 1.76 Ah) batteries [di-
mensions (each): 78 mm 34 mm 67 mm; weight (each):
0.90 kg]. The 12-V output from the batteries was connected
to the output side of the processing system (Fig. 3).
The power was distributed to the isolated input side of the pro-
cessing system using a dual isolated dc-to-dc converter (Burr-
Brown 722BG) (Fig. 3). The 722BG converted a single 12-V
dc input to a pair of bipolar output voltages ( 12 V) of the
same magnitude as the input voltage. The converter was capable
of providing a total maximum output current of 100 mA (per
output) at rated voltage. The two bipolar output supplies of the
converter were connected in parallel for higher output current
(2 100 mA).
D. Mechanical Construction of the Processing System
The printed circuit board (PCB) for the processing system
and the two sealed lead–acid batteries were enclosed in a Eu-
rocard black case (dimensions W, H, D: 247 mm 102 mm
220 mm). The esophageal pulse oximetry probe plugged into a
six-pin DIN socket on the front panel. The four analog output
channels (esophageal R and IR ac and dc PPGs) were taken from
a 68-pin vertically mounted male connector on the back panel
via a ribbon cable to a PCMCIA analog-to-digital card.
E. Software for Control and Analysis
All four PPG output signals were digitized by a 16-bit data
acquisition card (DAQCard-AI-16XE-50, National Instruments
Corporation, Austin, TX). The computer used for data acquisi-
tion, processing, displaying and data storage was a Dell Latitude
CPi D266XT laptop personal computer.
The digitized PPG signals were analyzed by a Virtual Instru-
ment (VI) implemented in LabVIEW (National Instruments Cor-
poration, Austin, TX). This VI read the esophageal PPG data,
converted them into a spreadsheet format and saved them into a
file specified by the user and displayed the signals in real time
on the screen of the laptop computer. Algorithms were also de-
veloped in the VI for the online estimation of esophageal SpO .
1) Analog Signal Acquisition: The PPG signals were sam-
pled at a rate of 100 samples per second for each of the four
channels. The analog filters described in Section II-B with a
maximum upper cutoff frequency of 20 Hz acted as anti-aliasing
filters.
2) Calculation of Ratio ( ) and Estimation of Esophageal
SpO : The algorithm used to estimate esophageal SpO calcu-
lated the ratio ( ) of the quotients of the ac and dc PPG ampli-
tudes at the R (655 nm) and IR (880 nm) wavelengths
(1)
The ratio ( ) was then used to compute the arterial oxygen
saturation (SpO ) using [19]
SpO (2)
This equation is a linear approximation to an empirical cali-
bration curve established by measurements on a large group of
healthy volunteers with arterial blood oxygen saturation (SaO )
values generally greater than 70% [19].
The Virtual Instrument algorithm calculated the amplitude of
the pulsatile ac PPG signal at each of the two wavelengths by
finding the difference between the maximum peak ( ) and
the minimum trough ( ) of approximately two consecutive
PPG cycles (over 2 s). The maximum dc PPG components for
both wavelengths were also found and the ratio calculated. A
running mean over five consecutive ratio values was taken and
this mean value of was displayed on the front panel of the VI.
The mean ratio value was then used in (2) to calculate SpO .
The value of SpO was updated every 2 s and displayed on the
front panel of the VI.
TABLE I
PATIENT DETAILS
F. Thermal Safety Tests
The emitters are thermally insulated from the tissue by the
1-mm-thick plastic wall of the esophageal tube and the oper-
ating current of the emitters is relatively low. However, temper-
ature tests both in vitro and in vivo, previously reported, were
conducted to confirm that temperature rises in the esophagus at
the outside wall of the esophageal tube adjacent to the probe
would not be of clinical significance [17].
III. PATIENTS AND MEASUREMENTS
Local research ethics committee approval was obtained prior
to commencing the study of ASA 2, 3, and 4 anesthetized pa-
tients. Forty-nine patients (40 male and 9 female) aged 26–81
years undergoing elective cardiothoracic surgery were recruited
to the study. Table I summarizes the number of patients per type
of operation. Patients with esophageal pathology or previous
surgery to the esophagus or stomach were excluded.
The trachea was intubated and the lungs were mechanically
ventilated using a Blease Manley MP3 ventilator. Ventilation
mode was, therefore, intermittent positive pressure ventilation
by a pressure generator ventilator. Intravenous access was estab-
lished with a 14-gauge cannula in a forearm vein. A 20-gauge
arterial cannula was placed in a radial artery to allow continuous
blood pressure monitoring during induction of anesthesia. The
right internal jugular vein was cannulated using a triple lumen
cannula to allow central venous pressure monitoring. Central
temperature was measured from the nasopharynx and peripheral
temperature from the left shoulder tip. The esophageal pulse
oximetry probe was inserted into a sealed 20 French gauge
stomach tube, which was lubricated with aqueous gel. The tube
was then inserted through the mouth into the esophagus under
direct vision. The stomach tube was advanced into the esophagus
until the end of the probe itself was 30 cm from the lips, as
indicated by a 30-cm mark previously positioned on the plastic
esophageal tube prior to insertion in the esophagus.
The probe was withdrawn slowly, and PPG signals were ob-
served at various depths of the esophagus to determine the op-
timal measuring site at which reliable signals with high SNR
were obtained. The probe was then left at this depth for the du-
ration of surgery and PPG traces and SpO values were recorded
simultaneously. During the esophageal measurements, values of
blood oxygen saturation from a commercial transmission type
finger pulse oximeter (Marquette, Tram 200A; Marquette Elec-
tronics, Milwaukee, WI) were also recorded.
Esophageal pulse oximetry monitoring was temporarily
stopped during transportation of the patient from the anesthetic
induction room into the operating room. Monitoring in theater
was intermittent. Esophageal data were collected before skin
incision for a period of 15 min, after sternotomy for 15 min,
prior to bypass for 15 min, after bypass for 45 min and postop-
eratively in the intensive care unit for up to 60 min.
During the above recording periods samples (approximately
1 ml) of arterial blood were drawn into 2-ml heparinised sy-
ringes and analyzed immediately by an Instrumentation Lab-
oratories IL 482 CO-oximeter or an Instrumentation Labora-
tories IL BG-1400 Blood Gas Analyzer (BGA) (Instrumenta-
tion Laboratories, Lexington, MA) depending on availability in
the clinical workplace. Calibration of the CO-oximeter was per-
formed according to the manufacturer’s instructions at weekly
intervals. This calibration was a one-point calibration at a level
of THb 14.9 g/dL using IL CalDye. The blood gas analyzer
executes a one-point calibration cycle every 30 min and after
every sample. A two-point calibration is executed every 4 h. The
PCO2 and PO2 electrodes are calibrated using certified gas stan-
dard mixtures. The pH electrode is calibrated using standardized
reagents. In addition, three quality-control standard samples are
measured daily to check the automated calibrations.
A. Data Analysis and Statistics
Patients were only accepted into the statistical analysis if
for every esophageal SpO value there was a corresponding
CO-oximetry or blood gas analysis estimate of arterial blood
oxygen saturation. The limits of agreement between the
esophageal SpO results and those from CO-oximetry and
blood gas analysis, were calculated using the between-method
differences analysis outlined by Altman and Bland [20], [21].
Bland and Altman suggest that the best way to compare two
methods is to plot the difference between the methods against
their mean. The level of agreement can be summarized by
calculating the bias, estimated by the mean difference ( ), and
the standard deviation of the differences ( ). Provided differ-
ences within 2 (limits of agreement) are not clinically
significant, the two methods can be used interchangeably.
Linear Regression analysis was used to compare the blood
oxygen saturation results from CO-oximetry and blood gas anal-
ysis with the R/IR ratio measured by the esophageal pulse
oximeter.
IV. RESULTS
A. Results From the Thermal Safety Tests
The rise in temperature at the outside surface of the
esophageal tube in the in vitro tests was no more than 0.2 C
for both the R and IR emitters. In the in vivo tests, the rise in
temperature at the outside surface of the esophageal tube was
less than 0.7 C for the R emitter and 0.6 C for the IR
emitter [17].
B. Results From the Investigation of Esophageal PPG Signals
in Cardiac Patients
It was found possible to record good quality PPG signals





Fig. 4. Esophageal PPG traces at various esophageal depths [(a) 30, (b)
25, (c) 18, and (d) 14 cm] obtained from an anesthetized patient undergoing
cardiopulmonary bypass surgery.
was always better than 40 dB at the output of the system. The
amplitudes of the signals varied with depth in the esophagus.
Fig. 4 depicts typical PPG traces from a CABG patient at var-
ious esophageal depths. As can be seen from Fig. 4 the ampli-
tudes of the PPG signals in the upper esophagus (14 and 18 cm)
are smaller than those in the lower esophagus (25 and 30 cm).
This was the trend in all patients.
C. Comparisons of Blood Oxygen Saturation Measurements
From the Esophageal Pulse Oximeter With Those From Blood
Gas Analysis
A total of 155 pairs of blood oxygen saturation measure-
ments were used for the between-method differences analysis
[20], [21]. An average ( SD) of 3.5 ( 1.5) blood samples were
collected from each patient.
Fig. 5. The difference between blood oxygen saturation values from the blood
gas analyzer and SpO readings obtained from the reflectance esophageal pulse
oximeter plotted against their mean for 49 patients.
A plot of the difference between blood oxygen saturation
values from the blood gas analyzer and SpO readings obtained
from the reflectance esophageal pulse oximeter against their
mean is shown in Fig. 5. The bias, estimated by the mean dif-
ference ( ), and the standard deviation of the differences ( )
give the degree of agreement between the two methods. The
mean difference ( ) (blood gas analysis minus esophageal pulse
oximeter) was 0.02% and the standard deviation ( ) was 0.9%.
The limits of agreement ( 2 ) were
%
%
A plot of oxygen saturation values from blood gas analysis
against the as measured by the esophageal pulse oximeter is
shown in Fig. 6. The equation of the best fit linear regression
line is: SpO 108.2 21.1 ; 0.74; standard error of
the estimate (SEE) 0.84; 0.001. The empirical calibration
equation [see (2), Section II-E2 ] [19] used for the estimation of
esophageal SpO from measured values of is given by the
dashed line in Fig. 6.
D. Comparisons of Blood Oxygen Saturation Measurements
From the Esophageal Pulse Oximeter With Those From
CO-Oximetry
Although not available routinely for the majority of patients,
CO-oximetry measurements were made on 17 patients. A total
of 36 pairs of blood oxygen saturation measurements were used
for a between-method differences analysis [20], [21]. An average
( SD) of 2.1 ( 1.2) blood samples were collected from each
patient. Fig. 7 shows a comparison of blood oxygen saturation
values measured by the CO-oximeter and the esophageal pulse
oximeter probe. The mean difference ( ) was 0.7% and the
standard deviation ( ) was 0.7%. The limits of agreement were
%
%
A plot of the oxygen saturation values from the CO-oximeter
against as measured by the esophageal pulse oximeter is
shown in Fig. 8. The equation of the best fit linear regression
Fig. 6. Plot of SaO from blood gas analysis against the R measured by the
esophageal pulse oximeter for 49 patients. The solid line represents the best fit
linear regression line: SpO = 108.2   21.1R; r = 0.74; SEE = 0.84; n =
155; p < 0.001. The dashed line represents the empirical calibration equation
SpO = 110   25R used for the estimation of esophageal SpO .
Fig. 7. The difference between blood oxygen saturation values from the
CO-oximeter and SpO readings obtained from the reflectance esophageal
pulse oximeter plotted against their mean for 17 patients.
Fig. 8. Plot of SaO from the CO-oximetry against the R measured by the
esophageal pulse oximeter for 17 patients. The solid line represents the best fit
linear regression line: SpO = 106.4   18.8R; r = 0.83; SEE = 0.58; n =
36; p < 0.001. The dashed line represents the empirical calibration equation
SpO = 110   25R used for the estimation of esophageal SpO .
line was SpO 106.4 18.8 ; 0.83; SEE 0.58;
36; 0.001 (solid line in Fig. 8). The dashed line in
Fig. 8 represents the empirical calibration equation [19] used
for the estimation of esophageal SpO .
Fig. 9. The difference between blood oxygen saturation values from the blood
gas analyzer and SpO readings obtained from the reflectance esophageal
pulse oximeter plotted against their mean for five patients when peripheral
pulse oximetry failed.
E. Patients in Whom Peripheral Pulse Oximetry Failed: Results
of the Esophageal Blood Oxygen Saturation Measurements
Of the 49 patients included in the study, five (10.2%)
had periods of at least 10 min during which the commercial
finger pulse oximeter failed continuously to record pulsatile
PPG signals and, thus, failed to estimate SpO values. The
esophageal pulse oximeter operated successfully during all
the periods when the commercial pulse oximeter failed. The
esophageal PPG traces obtained at both wavelengths were of
large amplitudes and had similar SNRs to those of patients in
whom there was no failure. An esophageal SpO was estimated
every 2 s with high reliability.
The five patients in whom peripheral pulse oximetry failure
occurred were all cardiac patients undergoing cardiothoracic by-
pass surgical procedures. In four of the patients, the finger pulse
oximeters failed postoperatively (within the first half hour after
completion of the surgery) in the intensive care unit and in the
fifth patient the failure occurred in the operating room before
the patient went on bypass.
During the period of commercial finger pulse oximeter
failure, blood samples (a total of seven samples for the five
patients) were collected and blood gas analysis was performed.
Esophageal pulse oximetry values were also recorded at the
same time as the blood sampling.
Fig. 9 shows a comparison of blood oxygen saturation values
measured by the blood gas analyzer and the esophageal pulse
oximeter probe using a Bland and Altman analysis [20], [21].
The mean difference ( ) was 0.0% and the standard deviation
( ) was 0.5%. The limits of agreement were
%
%
V. DISCUSSION AND CONCLUSION
The aim of this study was to develop and evaluate an
esophageal reflectance pulse oximeter, which would allow
accurate and reliable measurements of oxygen saturation in pa-
tients with compromised peripheral circulation. The hypothesis
was that blood flow to this central site may be preferentially
preserved. A miniature opto-electronic reflectance esophageal
oximeter probe, small enough to fit into a conventional stomach
tube (French gauge 20) was developed. A novel isolated
processing system, based on a LabVIEW Virtual Instrument,
was also designed to display esophageal PPGs and give an
online estimation of esophageal SpO values.
In none of the temperature tests, both in vitro and in vivo
previously reported, was a temperature rise in excess of 0.7 C
detected at the outside wall of the esophageal tube [17]. It is
concluded that there is negligible risk of thermal injury to the
esophagus when using this probe, as this temperature rise would
not be expected to result in tissue damage.
The results show that the esophageal probe can record good
quality R and IR ac and dc PPG signals from any depth within
the esophagus. The PPG amplitudes are generally higher in the
lower esophagus, probably because the chief blood supply of
the thoracic esophagus is either direct from the aorta or from
branches of the bronchial arteries. The cervical esophagus is
supplied mainly by branches of the inferior thyroid artery, which
may lead to reduced pulsatility, compared with that in the lower
esophagus supplied by the aorta. The present probe allows op-
timization of the signal by variation of the monitoring depth
and is, therefore, more versatile than the “transoesophageal”
probe described by Atlee and Bratanow and Prielipp et al. [12],
[15] which could only be positioned in the upper esophagus at
the cricopharyngeous muscle. Moreover, our experience indi-
cates that the PPG amplitudes are likely to be smaller near the
cricopharyngeous muscle than they are at greater depths. In any
particular patient, the optimal depth for esophageal monitoring
may also depend on the presence of abnormality, such as hiatus
hernia with esophageal dilatation and reflux of gastric contents.
In this study, patients with known esophageal disease, including
reflux, were excluded. In any case, the majority of our measure-
ments were derived from above the gastro-esophageal sphincter
region and, hence, above the level of a hiatus hernia and dilata-
tion.
In general, the esophageal PPG signals were adversely af-
fected by electrocautery. However electrocautery artifacts were
also present in the commercial pulse oximeter connected to the
patient’s finger. Similar problems have been reported by other
investigators [12]. The electronic components of the probe are
completely electrically insulated from the surrounding tissues
by the 1-mm-thick plastic wall of the stomach tube. There is no
evidence that the probe is damaged by electrocautery or defib-
rillation (internal or external) as the PPG signal recovered im-
mediately afterwards in all cases and continued to function sat-
isfactorily in multiple uses on subsequent patients. No attempt
was made to eliminate the electrocautery artifact in these ini-
tial measurements. Further investigations and development will
be required for artifact elimination, for example by radio-fre-
quency filtering or shielding [15].
The SpO results from the esophageal pulse oximeter
are in good agreement with blood oxygen saturation values
obtained from blood gas analysis and CO-oximetry. The limits
of agreement from the Bland and Altman analysis are 1.8%
for the blood gas analysis results and 0.7% and 2.1% for
the CO-oximetry results. In general, clinical practice limits of
agreement of less than 3% are considered acceptable [19].
It can reasonably be argued, therefore, that the estimation
of blood oxygen saturation by the methods of esophageal
pulse oximetry, blood gas analysis and CO-oximetry could
be used interchangeably in cardiothoracic surgery patients.
Fig. 5 illustrates that the differences between blood oxygen
saturation values from the blood gas analyzer and SpO read-
ings obtained from the reflectance esophageal pulse oximeter
differ by no more than 3%, except in one measurement, where
the difference is 4.5%. There appears to be no technical or
physiological reason for the observed deviation, and the PPG
signals were acceptable. Notwithstanding, the deviation is only
4.5%, which is less than the 10% observed deviation between
two commercial devices reported by Prielipp et al. [15]. The
algorithm that estimates esophageal SpO in our system was
designed to saturate at 100% as in commercial pulse oximeters.
This explains the linear relationship (see Fig. 5) between the
differences and the mean at mean values between 99% and
100% saturation.
The best fit lines to the plots of blood gas analyzer (Fig. 6)
and the CO-oximeter SaO results (Fig. 8) against the ratios
from the esophageal pulse oximeter are SpO 106.4 18.8
and SpO 108.2 21.1 , respectively. These equations are
in reasonable agreement with one another, although there were
more blood gas analyzer results ( 155) than CO-oximeter
values ( 36). The empirical calibration equation used in the
esophageal pulse oximeter is SpO 110 25 . The slope
and intercept of the empirical calibration line is higher than the
corresponding values for both best fit lines. The difference be-
tween the best fit lines and the empirical calibration line may
be due to the fact that the calibration equation is based on probe
wavelengths of 660 and 940 nm [19] instead of 655 and 880 nm
as used in the present probe. The accumulation of points in these
two figures (Figs. 6 and 8) at 0.4 results from the fact that the
algorithm estimating SpO is constrained to limit the maximum
saturation values to 100%.
Prielipp et al. [15] in their measurements at the cricopha-
ryngeous muscle in the esophagus concluded that a “transoe-
sophageal” oximetry probe was inferior to conventional finger
pulse oximeters. However, our preliminary measurements
below the cricopharyngeous muscle suggest that measurements
at these lower sites may permit more accurate values of blood
oxygen saturation to be made.
The esophageal pulse oximeter was found to be reliable and
accurate in those cases of poor peripheral perfusion when the
commercial finger pulse oximeter failed for at least 10 min. Five
(10.2%) of the 49 cardiothoracic patients studied, had a finger
pulse oximetry failure, which is in agreement with the previ-
ously reported incidence of failure [6]. Although the percentage
failure rate in this study is only approximately 10% in terms
of absolute numbers this would represent a significant clinical
problem and a reliable means of monitoring throughout such a
failure would be of real value.
These results show that in cardiothoracic patients the arterial
blood circulation to the esophagus is less subject to vasocon-
striction and decreased PPG amplitudes than the finger. There-
fore, the human esophagus can be used as an alternative SpO
monitoring site during surgery and in intensive care. Moreover,
these results suggest that the esophagus will continue to provide
reliable SpO values even when peripheral pulse oximeters fail.
Only five patients showed peripheral failure in this study and,
therefore, more work is needed to confirm these findings both
in cardiothoracic and other patients.
In summary, a new and clinically useful minimally invasive
esophageal pulse oximetry system has been successfully devel-
oped and evaluated. It shows promise for the reliable monitoring
of SpO in patients undergoing prolonged surgical procedures.
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